These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synthesis and study of controlled release of ofloxacin from polyester conjugates. Sobczak M; Nałęcz-Jawecki G; Kołodziejski WL; Goś P; Zółtowska K Int J Pharm; 2010 Dec; 402(1-2):37-43. PubMed ID: 20888401 [TBL] [Abstract][Full Text] [Related]
4. Multilayer, degradable coating as a carrier for the sustained release of antibiotics: preparation and antimicrobial efficacy in vitro. Guillaume O; Garric X; Lavigne JP; Van Den Berghe H; Coudane J J Control Release; 2012 Sep; 162(3):492-501. PubMed ID: 22902589 [TBL] [Abstract][Full Text] [Related]
5. Glyceryl monooleate-based otic delivery system of ofloxacin: release profile and bactericidal activity. Adwan S; Abu-Dahab R; Al-Bakri AG; Sallam A Pharm Dev Technol; 2015 May; 20(3):361-6. PubMed ID: 24392877 [TBL] [Abstract][Full Text] [Related]
6. Polyvinylpyrrolidone oral films of enrofloxacin: film characterization and drug release. Kumar GP; Phani AR; Prasad RG; Sanganal JS; Manali N; Gupta R; Rashmi N; Prabhakara GS; Salins CP; Sandeep K; Raju DB Int J Pharm; 2014 Aug; 471(1-2):146-52. PubMed ID: 24858388 [TBL] [Abstract][Full Text] [Related]
7. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin. Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796 [TBL] [Abstract][Full Text] [Related]
8. The bactericidal activity of ofloxacin against staphylococci. Lewin CS; Smith JT J Chemother; 1989 Jul; 1(4 Suppl):151-3. PubMed ID: 16312348 [No Abstract] [Full Text] [Related]
9. Formulation and Evaluation of Novel Solid Lipid Microparticles for the Sustained Release of Ofloxacin. Hooda A; Sradhanjali M; Popsy Pharm Nanotechnol; 2017; 5(4):329-341. PubMed ID: 29278216 [TBL] [Abstract][Full Text] [Related]
10. Ofloxacin: antibacterial activity, induction of resistance and killing curves. Husson MO; Izard D; Bryskier A; Leclerc H Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716 [TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial activity and action mechanism of ofloxacin]. Padeĭskaia EN Antibiot Khimioter; 1996; 41(9):13-23. PubMed ID: 9005780 [No Abstract] [Full Text] [Related]
12. Solution studies on binary and ternary complexes of copper(II) with some fluoroquinolones and 1,10-phenanthroline: Antimicrobial activity of ternary metalloantibiotics. Gameiro P; Rodrigues C; Baptista T; Sousa I; de Castro B Int J Pharm; 2007 Apr; 334(1-2):129-36. PubMed ID: 17118587 [TBL] [Abstract][Full Text] [Related]
13. Nanostructure formation in aqueous solution of amphiphilic copolymers of 2-(N,N-dimethylaminoethyl)methacrylate and alkylacrylate: Characterization, antimicrobial activity, DNA binding, and cytotoxicity studies. Dutta P; Dey J; Shome A; Das PK Int J Pharm; 2011 Jul; 414(1-2):298-311. PubMed ID: 21600968 [TBL] [Abstract][Full Text] [Related]
14. Antibacterial effects of poly(2-(dimethylamino ethyl)methacrylate) against selected gram-positive and gram-negative bacteria. Rawlinson LA; Ryan SM; Mantovani G; Syrett JA; Haddleton DM; Brayden DJ Biomacromolecules; 2010 Feb; 11(2):443-53. PubMed ID: 20025269 [TBL] [Abstract][Full Text] [Related]
15. [In vitro fluoroquinolone resistance in ocular bacterial isolates]. Sun XG; Wang ZQ; Li R; Chen L; Jin XY; Luo SY Zhonghua Yan Ke Za Zhi; 2003 Mar; 39(3):163-6. PubMed ID: 12880574 [TBL] [Abstract][Full Text] [Related]
16. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens. Hirokawa Y; Kinoshita H; Tanaka T; Nakata K; Kitadai N; Fujimoto K; Kashimoto S; Kojima T; Kato S J Med Chem; 2008 Apr; 51(7):1991-4. PubMed ID: 18330977 [TBL] [Abstract][Full Text] [Related]
17. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin. Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153 [TBL] [Abstract][Full Text] [Related]
18. Controlled release of levofloxacin sandwiched between two plasma polymerized layers on a solid carrier. Vasilev K; Poulter N; Martinek P; Griesser HJ ACS Appl Mater Interfaces; 2011 Dec; 3(12):4831-6. PubMed ID: 22103351 [TBL] [Abstract][Full Text] [Related]
19. Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis. Ustündağ-Okur N; Gökçe EH; Bozbıyık Dİ; Eğrilmez S; Ozer O; Ertan G Eur J Pharm Sci; 2014 Oct; 63():204-15. PubMed ID: 25111119 [TBL] [Abstract][Full Text] [Related]